43X Gains in 5 Years? Read This

Economic Super Convergence Event

43X Gains in 5 Years? Read This

Nomi PrinsHi Paul,

A major FDA decision has created a huge stir all across the mainstream media.

But there’s no debating the $16 billion windfall it created overnight.

Now, legendary tech expert Ray Blanco says it’s created a unique opportunity for one small biotech company.

I’m talking about the chance for potential 10X or even 43X gains over the next 5 years.

Click here now to see his urgent findings.

But it’s critical that you view this briefing now before it’s too late.

Regards,

Dr. Nomi Prins

Please note: We sent this e-mail to you because you signed up for The Economic Super Convergence Event. Unsubscribe from this mailing list by clicking here.

Paradigm Press© 2021 Paradigm Press, LLC. All Rights Reserved. Protected by copyright laws of the United States and international treaties. This Newsletter may only be used pursuant to the subscription agreement and any reproduction, copying, or redistribution (electronic or otherwise, including on the world wide web) , in whole or in part, is strictly prohibited without the express written permission of Paradigm Press, LLC. 808 Saint Paul Street, Baltimore MD 21202.

Nothing in this e-mail should be considered personalized financial advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed as personalized financial advice. We expressly forbid our writers from having a financial interest in any security recommended to our readers. All of our employees and agents must wait 24 hours after on-line publication or 72 hours after the mailing of printed-only publication prior to following an initial recommendation. Any investments recommended in this letter should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company.

No comments:

Post a Comment